Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
2.700
-0.050 (-1.82%)
At close: Sep 25, 2026, 4:00 PM EDT
2.750
+0.050 (1.85%)
After-hours: Sep 25, 2026, 7:40 PM EDT
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $255.61 million as of September 25, 2026. Its market cap has increased by 133.13% in one year.
Market Cap
255.61M
Enterprise Value
118.70M
1-Year Change
133.13%
Ranking
Category
Stock Price
$2.70
ChartMarket Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $255.61M, a decrease of -56.49%. That is a compound annual growth rate of -12.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 255.61M | 192.42% |
| Dec 31, 2025 | 87.41M | -59.52% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 272.51M |
| Lexeo Therapeutics | 271.56M |
| Greenwich LifeSciences | 267.44M |
| Sutro Biopharma | 264.97M |
| Q32 Bio | 261.08M |
| Lineage Cell Therapeutics | 260.49M |
| Bicycle Therapeutics | 257.92M |
| Palisade Bio | 252.69M |